Clinical investigation on the effects of biological agents on asthma and search for biological markers - Clinical effects and biomarkers of biological agents on asthma

MORI AKIO0 sites12 target enrollmentMay 28, 2019

Overview

Phase: N/A
Intervention: Not specified
Conditions: Not specified
Sponsor: MORI AKIO
Enrollment: 12
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

Biomarkers associated with the effects of biological agents were aimed by the current investigation, which was unfortunately suspended due to the quit of the supporting grant. Further enrollment or follow up of the patients was not possible. Biomarkers associated with the biological agents would greatly ease economical and clinical needs in this field.

Registry

who.int

Start Date

May 28, 2019

End Date

March 31, 2021

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

MORI AKIO

Eligibility Criteria

Inclusion Criteria

•1\) Asthma patients diagnosed based on Japanese Asthma Prevention and Management Guideline 2018 who are older than 12 years old
•2\) Either anti\-IgE antibody (Zorea), anti\-IL\-5 antibody (Nucala), or anti\-IL\-5 receptor antibody (Facenra) is going to be administered.
•3\) Written informed consent from the patients or the legal gardian is obtained.

Exclusion Criteria

•1\) Those patients who can not be taken blood sample
•2\) Those patients who were judged not suitable for the entry to this investigation be the responsible doctor